Compounds > promegestone
Page last updated: 2024-08-23

promegestone and Carcinoma, Anaplastic

promegestone has been researched along with Carcinoma, Anaplastic in 6 studies

Research

Studies (6)

TimeframeStudies, this research(%)All Research%
pre-19903 (50.00)18.7374
1990's3 (50.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Archer, TK; Moyer, ML; Nordeen, SK; Zaniewski, E1
Joosten, JW; Kloosterboer, HJ; Schoonen, WG1
Auricchio, F; Beato, M; Bilancio, A; Castoria, G; Di Domenico, M; Gong, W; Lombardi, M; Migliaccio, A; Piccolo, D1
Lloyd, RV1
Edwards, DP; Elashry-Stowers, D; Speers, WC; Zava, DT1
Bosman, FT; De Goeij, AF; Hondius, GG; Rousch, MJ; Scheres, HM1

Other Studies

6 other study(ies) available for promegestone and Carcinoma, Anaplastic

ArticleYear
The differential capacity of glucocorticoids and progestins to alter chromatin structure and induce gene expression in human breast cancer cells.
    Molecular endocrinology (Baltimore, Md.), 1994, Volume: 8, Issue:9

    Topics: Breast Neoplasms; Carcinoma; Chromatin; Dexamethasone; DNA-Binding Proteins; Gene Expression Regulation, Neoplastic; Gene Expression Regulation, Viral; Genes, Reporter; Humans; Mammary Tumor Virus, Mouse; NFI Transcription Factors; Promegestone; Promoter Regions, Genetic; Receptors, Glucocorticoid; Receptors, Progesterone; Transcription Factors; Tumor Cells, Cultured

1994
Effects of two classes of progestagens, pregnane and 19-nortestosterone derivatives, on cell growth of human breast tumor cells: II. T47D cell lines.
    The Journal of steroid biochemistry and molecular biology, 1995, Volume: 55, Issue:3-4

    Topics: Breast Neoplasms; Carcinoma; Cell Division; Desogestrel; Dose-Response Relationship, Drug; Estradiol; Estrenes; Estrogen Antagonists; Female; Furans; Humans; Levonorgestrel; Medroxyprogesterone Acetate; Mifepristone; Nandrolone; Norethindrone; Norpregnenes; Pregnanes; Pregnenediones; Progesterone; Promegestone; Tumor Cells, Cultured

1995
Activation of the Src/p21ras/Erk pathway by progesterone receptor via cross-talk with estrogen receptor.
    The EMBO journal, 1998, Apr-01, Volume: 17, Issue:7

    Topics: Animals; Breast Neoplasms; Carcinoma; COS Cells; CSK Tyrosine-Protein Kinase; Enzyme Activation; Enzyme Inhibitors; Epidermal Growth Factor; Estradiol; Gene Expression Regulation; Guanosine Triphosphate; Hormone Antagonists; Humans; Mitogen-Activated Protein Kinase 1; Point Mutation; Promegestone; Protein-Tyrosine Kinases; Proto-Oncogene Proteins p21(ras); Receptors, Estrogen; Receptors, Progesterone; Signal Transduction; src-Family Kinases; Tamoxifen; Transcriptional Activation; Tumor Cells, Cultured

1998
Studies on the progesterone receptor content and steroid metabolism in normal and pathological human breast tissues.
    The Journal of clinical endocrinology and metabolism, 1979, Volume: 48, Issue:4

    Topics: Adenofibroma; Binding, Competitive; Breast; Breast Diseases; Breast Neoplasms; Carcinoma; Female; Humans; Kinetics; Progesterone; Promegestone; Receptors, Progesterone

1979
Immunocytochemical localization of progesterone receptors in breast cancer with anti-human receptor monoclonal antibodies.
    Cancer research, 1988, Nov-15, Volume: 48, Issue:22

    Topics: Antibodies, Monoclonal; Antibody Specificity; Breast Neoplasms; Carcinoma; Cell Nucleus; Cytosol; Estrenes; Female; Humans; Immunohistochemistry; Mifepristone; Molecular Weight; Promegestone; Receptors, Estrogen; Receptors, Glucocorticoid; Receptors, Progesterone

1988
Progesterone receptor quantification with radiolabeled promegestone (R 5020) in frozen sections of endometrium and breast cancer tissue.
    Journal of steroid biochemistry, 1988, Volume: 29, Issue:5

    Topics: Animals; Breast Neoplasms; Carcinoma; Cattle; Endometrium; Female; Freezing; Humans; Kinetics; Lipids; Promegestone; Receptors, Progesterone; Solubility

1988